CIK 0001680048
- Non-accelerated filer
- Smaller reporting company
MUSTANG BIO, INC.
Sign in to watch- Ticker
- MBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 473828760
- Phone
- +1 781-652-4500
- Business address
- 95 SAWYER RD, SUITE 110, WALTHAM, MA, 02453
- 4 Grant or award Director acquired 7,246 shares (grant or award)
- 4 Grant or award President and CEO acquired 5,000 shares (grant or award)
- 3/A Insider 3/A
- 3/A Insider 3/A
- 4 Open-market buy Director bought 10,000 shares at an average $0.63 ($6,277)
- 4 Open-market buy Director bought 9,094 shares at an average $0.62 ($5,607)
- 4 Grant or award Director acquired 71,664 shares (grant or award)
- 4 Grant or award Director acquired 71,664 shares (grant or award)
- 4 Grant or award Director acquired 71,664 shares (grant or award)
- 4 Grant or award Director acquired 71,664 shares (grant or award)
- 4 Grant or award 10% owner acquired 2,807,008 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale SVP, Fin. & Corp. Controller sold 4,374 shares at $1.83 ($8,004)
- 4 Open-market buy President and CEO bought 65,000 shares at $2.24 ($145,600)
- 4 Open-market sale SVP, Fin. & Corp. Controller sold 4,450 shares at $2.28 ($10,146)
- 4 Grant or award Director acquired 1,170 shares (grant or award)
- 4 Grant or award President and CEO acquired 2,746 shares (grant or award)
- 4 Open-market buy President and CEO bought 86,206 shares at $2.91 ($250,859)
- 4 Grant or award Director acquired 13,774 shares (grant or award)
- 4 Grant or award Director acquired 13,774 shares (grant or award)
Page 2 of 5 · 85 filings